Tumor-Associated Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

PURPOSE: Tumor-associated lymphocyte numbers in breast cancer have been suggested as a new independent predictor of response to neoadjuvant chemotherapy in breast cancer patients. We therefore evaluated the relationship between pathologic complete response (pCR) and tumor-associated lymphocytes in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hee Jin, Seo, Jin-Young, Ahn, Jin-Hee, Ahn, Sei-Hyun, Gong, Gyungyub
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625767/
https://www.ncbi.nlm.nih.gov/pubmed/23593079
http://dx.doi.org/10.4048/jbc.2013.16.1.32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625767/
https://www.ncbi.nlm.nih.gov/pubmed/23593079
http://dx.doi.org/10.4048/jbc.2013.16.1.32

Ejemplares similares